Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

被引：0

作者：

Blauvelt, Andrew ^{[1
]}

Ardern-Jones, Michael R. ^{[2
,3
]}

Bieber, Thomas ^{[4
]}

Hong, Chih-Ho ^{[5
,6
,7
]}

Chu, Chia-Yu ^{[8
,9
]}

Liu, Meng ^{[10
]}

Yang, Yang ^{[10
]}

Ladizinski, Barry ^{[10
]}

Teixeira, Henrique D. ^{[10
]}

Calimlim, Brian M. ^{[10
]}

Thyssen, Jacob P. ^{[11
]}

机构：

[1] Oregon Med Res Ctr, Portland, OR USA

[2] Univ Hosp Southampton NHS Fdn Trust, Southampton Gen Hosp, Dept Dermatol, Southampton, Hants, England

[3] Univ Southampton, Clin Expt Sci, Fac Med, Southampton, Hants, England

[4] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany

[5] Dr Chih ho Hong Med Inc, Surrey, BC, Canada

[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada

[7] Prob Med Res, Surrey, BC, Canada

[8] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan

[9] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[10] AbbVie Inc, N Chicago, IL USA

[11] Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

28032

引用

页码：AB171 / AB171

页数：1

共 50 条

[31] ABSOLUTE EASI TARGET IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF DATA FROM THE MEASURE UP 1 AND 2 STUDIES
Prajapatil, Vimal
Simpson, Eric L.
Thyssen, Jacob P.
Chovatiya, Raj
Lane, Michael
Teixeira, Henrique
Calimlim, Brian
Silverberg, Jonathan I.
ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 33 - 33
[32] Effects of upadacitinib on patient-reported symptoms of atopic dermatitis: Atopic Dermatitis Symptom Scale (ADerm-SS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)
Silverberg, Jonathan I.
Thyssen, Jacob P.
Rosmarin, David
Pink, Andrew E.
Calimlim, Brian M.
Teixeira, Henrique D.
Hu, Xiaofei
Yang, Yang
Thaci, Diamant
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB7 - AB7
[33] Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials
Simpson, Eric L.
Papp, Kim A.
Blauvelt, Andrew
Chu, Chia-Yu
Hong, H. Chih-Ho
Katoh, Norito
Calimlim, Brian M.
Thyssen, Jacob P.
Chiou, Albert S.
Bissonnette, Robert
Gold, Linda F. Stein
Wegzyn, Colleen
Hu, Xiaofei
Liu, Meng
Liu, John
Tenorio, Allan R.
Chu, Alvina D.
Guttman-Yassky, Emma
JAMA DERMATOLOGY, 2022, 158 (04) : 404 - 413
[34] Safety and efficacy of upadacitinib monotherapy in adolescents and adults with moderate-to-severe atopic dermatitis: results from two pivotal, phase III, randomized, double-blinded, monotherapy, placebo-controlled studies (Measure Up 1 and Measure Up 2)
Guttman-Yassky, E.
Teixeira, H. D.
Simpson, E. L.
Papp, K. A.
Pangan, A. L.
Blauvelt, A.
Thaci, D.
Chu, C. Y.
Hong, H. C.
Katoh, N.
Paller, A. S.
Calimlim, B.
Gu, Y.
Hu, X.
Liu, M.
Yang, Y.
Tenorio, A. R.
Chu, A. D.
Irvine, A. D.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E62 - E62
[35] Characterization of haematological and transaminase laboratory findings associated with upadacitinib use in moderate-to-severe atopic dermatitis: results of two phase III Trials (Measure Up 1 and 2)
Silverberg, J. I.
Gooderham, M. J.
de Bruin-Weller, M. S.
Papp, K. A.
Aoki, V.
Paller, A. S.
Ofori, S.
Tenorio, A. R.
Liu, Y.
Liu, J.
Chovatiya, Raj
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E168 - E169
[36] Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up)
Simpson, Eric L.
Costanzo, Antonio
Prajapati, Vimal H.
Calimlim, Brian M.
Chu, Alvina D.
Wu, Tianshuang
Eyerich, Kilian
BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II30 - II31
[37] UPADACITINIB VERSUS DUPILUMAB IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF THE HEADS UP PHASE 3 TRIAL
Blauvelt, Andrew
Teixeira, Henrique D.
Simpson, Eric L.
Costanzo, Antonio
De Bruin-Weller, Marjolein
Barbarot, Sebastien
Prajapati, Vimal H.
Lio, Peter
Hu, Xiaofei
Wu, Tianshuang
Liu, John
Ladizinski, Barry
Chu, Alvina D.
Eyerich, Kilian
ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 62 - 62
[38] Improvement in patient global impression measures with upadacitinib with or without topical corticosteroids in moderate to severe atopic dermatitis: Results from placebo-controlled phase 3 studies
Gooderham, M.
Deleuran, M.
Gold, L. S.
Calimlim, B.
Zeng, J.
Takemoto, S.
Raymundo, E.
Weidinger, S.
EXPERIMENTAL DERMATOLOGY, 2021, 30 : 16 - 17
[39] Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Silverberg, Jonathan I.
Gooderham, Melinda J.
Paller, Amy S.
Deleuran, Mette
Bunick, Christopher G.
Gold, Linda F. Stein
Hijnen, Dirkjan
Calimlim, Brian M.
Lee, Wan-Ju
Teixeira, Henrique D.
Hu, Xiaofei
Zhang, Shiyu
Yang, Yang
Grada, Ayman
Platt, Andrew M.
Thaci, Diamant
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (03) : 485 - 496
[40] Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Jonathan I. Silverberg
Melinda J. Gooderham
Amy S. Paller
Mette Deleuran
Christopher G. Bunick
Linda F. Stein Gold
DirkJan Hijnen
Brian M. Calimlim
Wan-Ju Lee
Henrique D. Teixeira
Xiaofei Hu
Shiyu Zhang
Yang Yang
Ayman Grada
Andrew M. Platt
Diamant Thaçi
American Journal of Clinical Dermatology, 2024, 25 : 485 - 496

← 1 2 3 4 5 →